Source:
Generated By: https://synbiohub.org/public/igem/igem2sbol/1
Created by: Julius Rabl
Date created: 2008-10-28 12:00:00
Date modified: 2015-05-08 01:10:22
lacI IS mutant R197A with RBS and terminator
| Types | DnaRegion |
| Roles | engineered_region Generator |
| Sequences | BBa_K142008_sequence (Version 1) |
Description
lacI IS mutant (IPTG unresponsive) with ribosome binding site and terminator
?????????Short description:????????? The lacI IS mutant is almost identical to the lacI transcriptional regulator except for the difference that it is not able to bind IPTG or allolactose due to a mutation; it therefore can not be activated by induction with these substances. Since it recognizes the same motif in the lac promotor region, it strongly represses transcription of all genes regulated by promotors with lacI binding site even if IPTG or allolactose are present. It can be used to terminate the expression of proteins under lac control if IPTG can not be removed from the cell rapidly.
?????????Detailed description:????????? Expression of the lac operon in E. coli is tightly controlled by lacI, a protein, which binds to a repressor binding site within the promotor and disables transcription by obscuring the promotor region. When bound to DNA, lacI is in the tetrameric form, which consists of two dimers interacting at the end distal from the DNA binding site. Upon binding of allolactose or IPTG, the tetramer breaks down into two dimers and the affinity for the repressor binding site is greatly reduced; the lacI IPTG complex will diffuse away from the repressor binding site, leaving the promotor accessible. As a result of decades of genetic and structural studies, the function of lacI is now understood on the molecular level (1, 2). Mutational experiments have identified residues, which abolish IPTG response upon mutation (3). Furthermore, the x-ray crystal structure of lacI with bound IPTG has allowed the identification of residues that interact with IPTG and which are promising targets for mutagenesis (1). We decided to mutate residues R197 and T276, which are located in the IPTG binding groove, contact IPTG and have been shown to produce the lacI IS mutation in previous genetic experiments. Since a quantitative study of the strength of inhibition by different lacI IS mutants has to our knowledge not been published so far, we decided to generate a set of eight mutated lacIs, in which we replaced either R197 with alanine or phenylalanine or T276 with alanine or phenylalanine or both in all possible combinations.
lacIIS-1: R197A
lacIIS-2: R197F
lacIIS-3: T276A
lacIIS-4: T276F
lacIIS-5: R197A T276A
lacIIS-6: R197A T276F
lacIIS-7: R197F T276A
lacIIS-8: R197F T276F
This BioBrick is based on BioBrick I763026 and contains a ribosome binding site, the lacI IS gene and a double terminator. As sequencing by Caltech has shown that BioBrick I763026 did not have a promotor this BioBrick is promotorless, too. Expression of the mutant LacI IS (and silencing of lac-controlled gene expression) can therefore be controlled by any promotor of choice if this BioBrick is cloned behind it.
References:
(1) Lewis, M., Chang, G., Horton, N. C., Kercher, M. A., Pace, H. C., Schumacher, M. A., Brennan, R. G., and Lu, P. (1996) Crystal structure of the lactose operon repressor and its complexes with DNA and inducer. Science 271, 1247-54.
(2) Friedman, A. M., Fischmann, T. O., and Steitz, T. A. (1995) Crystal structure of lac repressor core tetramer and its implications for DNA looping. Science 268, 1721-7.
(3) Suckow, J., Markiewicz, P., Kleina, L. G., Miller, J., Kisters-Woike, B., and Muller-Hill, B. (1996) Genetic studies of the Lac repressor. XV: 4000 single amino acid substitutions and analysis of the resulting phenotypes on the basis of the protein structure. J Mol Biol 261, 509-23.
Notes
During site-directed mutagenesis, the codons to be mutated were replaced with the most highly utilized codons in E. coli to prevent complications from the use of rare codons. The lacI IS sequences were analyzed for BioBrick restriction sites within the coding sequence to ensure their compatibility.Source
The lacI IS mutant presented derive from the BioBrick I763026, which as it turned out during sequencing by the Caltech team, did not have a promotor. Site-directed mutagenesis was performed by PCR, subsequent DpnI digest and transformation. The following primers were used for mutagenesis:R197F forward
CGGCGCGTCTGTTTCTGGCTGGCTG
R197A forward
CGGCGCGTCTGGCGCTGGCTGGCTG
R197F reverse
CAGCCAGCCAGAAACAGACGCGCCG
R197A reverse
CAGCCAGCCAGCGCCAGACGCGCCG
T276F forward
GGATACGACGATTTTGAAGACAGCTC
T276A forward
GGATACGACGATGCGGAAGACAGCTC
T276F reverse
GAGCTGTCTTCAAAATCGTCGTATCC
T276A reverse
GAGCTGTCTTCCGCATCGTCGTATCC
| Access | Instance | Definition |
| public public public public | BBa_B0034 BBa_K142000 BBa_B0010 BBa_B0012 | BBa_B0034 BBa_K142000 BBa_B0010 BBa_B0012 |